21 Nov 2019
AFT's bottom line benefits from licensing deal
Pharmaceutical company AFT is back in the black after seeing stronger sales of its over-the-counter medicines in Australasia and global markets as well.
Recent stories from Business News
Get the RNZ app
for easy access to all your favourite programmes
